MG
ACGN

Michael Gelband’s Aceragen Inc ACGN Stock Holding History

Michael Gelband’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,521
Closed -$27K – 2741
2021
Q3 		$27K Buy
1,521
+701
+85% +$12.6K ﹤0.01% 2007
2021
Q2 		$17K Sell
820
-910
-53% -$18.3K ﹤0.01% 2257
2021
Q1 		$38K Sell
1,730
-250
-13% -$18.7K ﹤0.01% 2043
2020
Q4 		$123K Buy
+1,980
New +$114K ﹤0.01% 1809

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Michael Gelband's ACGN Position: Q4 2021 in Review

Michael Gelband sold out of Aceragen Inc (ACGN) in Q4 2021, closing a stake of 1,521 shares — an estimated $27K sold.

Michael Gelband first reported a position in ACGN in Q4 2020 and held it in 4 quarters. The position peaked at $123K in Q4 2020. 34 funds tracked by Wall St. Rank hold ACGN as of Q4 2021.

  • Michael Gelband reported no remaining Aceragen Inc position as of Q4 2021 after selling out during the quarter.
  • Michael Gelband sold 1,521 Aceragen Inc shares in Q4 2021, an estimated $27K.
  • Michael Gelband first reported a position in Aceragen Inc in Q4 2020 and held it in 4 quarters.
  • Michael Gelband's Aceragen Inc position peaked at $123K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.